HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation ...
HCW Biologics received an extension from Nasdaq to regain compliance with listing rules by April 25 and June 15, 2025. HCW Biologics Inc., a clinical-stage biopharmaceutical company focused on ...